Key result
The coexistence of coronary artery disease with anemia is associated with an increased risk of death, myocardial infarction, and bleeding complications, adversely affecting PCI outcomes.
Why the study?
Does anemia worsen clinical outcomes in patients with coronary artery disease treated with percutaneous coronary intervention?
Does anemia worsen clinical outcomes in patients with coronary artery disease treated with percutaneous coronary intervention?
Anemia is a common comorbidity in patients with acute coronary syndromes that significantly worsens prognosis and increases bleeding risk, highlighting the need for routine hemoglobin evaluation upon admission.
Answers are grounded in this paper and cite their sources.
May support anemia screening before PCI; leaves open whether correction improves outcomes in trials.
Coexistence of coronary artery disease with anemia is associated with an increased risk of death, myocardial infarction and bleeding complications. Presence of anemia adversely affects the outcomes of percutaneous coronary intervention, in particular in acute coronary intervention (ACS). Incidence of anemia in patients with ACS is relatively high (approx. 19-30%), so hemoglobin levels should be evaluated upon admission, and considered in risk stratification.
No takes yet. Share an insight, caveat, or question.
Wańha et al. (2012) conducted a review in Coronary artery disease with anemia. Anemia vs. Normal hemoglobin levels was evaluated. The coexistence of coronary artery disease with anemia is associated with an increased risk of death, myocardial infarction, and bleeding complications, adversely affecting PCI outcomes.
Synapse has enriched 10 related papers. Consider them for comparative context: